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 Anthonisen P, et al.  Buscaglia A J, et al.  Campbell A, et al. 
Randomization  ‐  ‐  ‐ 
Concealed Allocation  ‐  ‐  ‐ 
Baseline Comparability  1  1  ‐ 
Blind Subjects  ‐  ‐  ‐ 
Blind Therapists  ‐  ‐  ‐ 
Blind Assessors  ‐  ‐  ‐ 
Adequate Follow‐up  ‐  1  1 
Intention‐to‐Treat  ‐  1  ‐ 
Between Group  ‐  1  1 
Point Estimates and Variability  ‐  ‐  1 


















































































































































































































Subject  1  2  3  4  5  6  7  8  9  10 
Initial Sitting  91.5  95  93  93  94  90  92  92  93  95 
Ending Sitting  93.5  94.5  92  95  94  91  92.5  92  93  95 
Mean Change  2  ‐0.5  ‐1  2  0  1  0.5  0  0  0 
 
Overall, the authors reported that there were no statistically significant changes after chest physical 
therapy.  However, the authors analyzed pre‐treatment to post‐treatment between‐subjects (mean 
change score).  With no baseline similarity between subjects reliably presented, this would not be an 
appropriate analysis.  It is also worth noting that a pulse oximeter does not report oxygen saturation with 
decimals (e.g., 0.5) and I do not know where the authors may have gotten these numbers.    
In Table 3, I evaluated the data within‐subject and found that after chest physical therapy, four subjects 
had a positive change, three had no change and two had a negative change in SpO2. 
Though no MCID was reported for SpO2, I would strongly suggest that if one were found, a positive 
change of two or a negative change of one would likely not be clinically significant for two reasons.  First, 
most patients would not notice a difference in their oxygen saturation, depending of where they were on 
the oxyhemoglobin dissociation curve.  Second, the accuracy of the oximeter is variable.  In 1999, Amal 
Jubran stated the average accuracy of pulse oximeters is <2% (SD: <3%) when actual arterial blood gas 
oxygen saturation is above 90%.  The accuracy can vary widely when SaO2 is below 80% or other factors 
such as anemia and poor perfusion of extremities is involved.  None of the ten subjects experienced a 
clinically significant change: none of the subjects’ oxygen saturation was below 90% and none had more 
than a 2% change in SpO2.  
Applicability of study results:  
Benefits vs. Costs:  There were limited costs to this chest PT treatment: therapist wages and time and money to 
educate therapist in the chest PT technique (which is an entry‐level PT skill).  There was negligible cost to 
the patient in terms of their time; they were in the hospital recovering regardless of the treatment given.  
No adverse events were reported.  Regardless of the limited costs of this treatment, there was no 
evidence that this treatment was effective because there was no statistically or clinically significant 
increase in SpO2 due to the chest PT treatment.  However, the major threats to the internal validity of this 
study have put the outcomes into question.  Furthermore, chest PT was designed as a treatment to 
reduce lung secretions; this study’s subjects did not suffer from copious amounts of secretions.  The study 
design was such that patients with secretions were excluded.  Therefore, I question why the authors 
chose these subjects and am not surprised there was no benefit of chest PT for these subjects. There is no 
benefit of this treatment for a patient population without copious lung secretions.   
Feasibility of treatment:  Though the cost is low, the treatment procedure was stated in detail, and most hospitals 
have access to equipment and therapists, there was no change in SpO2 from the beginning to the end of 
treatment.  Chest PT should likely not be a treatment of choice for acute exacerbations of COPD for 
patients with limited to no sputum production.   
Summary of external validity:  The patent population does not appear to be similar to most inpatient populations 
suffering from acute exacerbations of COPD and the compromise to internal validity is such that these 
study results cannot be generalized to other populations.  Also, the exclusion criteria would also make it 
difficult to generalize the outcomes of this study to other populations who often have co‐morbidities and 
sputum production.  
Discussion/Synthesis:  The purpose of the articles by Anthonisen et al. and Buscagla et al. was to assess the 
appropriateness of chest physical therapy as a treatment for acute exacerbations of COPD.  Anthonisen et 
al. assessed sputum volume and PaO2, while Buscagla et al. assessed SpO2.  Both articles had significant 
threats to internal validity.  Anthonisen et al. had seven threats ranging from major to minor: lack of 
randomization and statistical analysis of similarities at baseline, lack of power analysis and intention‐to‐
treat, and lack of a true control group and blinding.  Independently, each missing validity threat would not 
have been significant, but together, they threaten the validity of the outcomes and the study was given a 
PEDro score 1/10.  Buscagla et al. had two major threats: lack of randomization and no control group.  The 
authors addressed validity of the outcome measurement tool and a strict protocol was reported.  Though 
this study was given a PEDro score of 4/10, the study population was not appropriate for the intervention.  
The exclusion criteria included that all subjects with sputum production were eliminated.  However, 
sputum production is the main indication for chest PT.  With both studies lacking strong internal validity 
and one article lacking appropriate subjects, neither can be used to answer my clinical question.  At this 
time, more research needs to be completed with stronger protocols and study designs to answer the 
question of whether chest physical therapy is an appropriate treatment for patients suffering from acute 
exacerbations of COPD. 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